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Nephronophthisis (NPHP) comprises a group of autosomal recessive cystic kidney diseases, which constitute the
most frequent genetic cause for end-stage renal failure in children and young adults. The most prominent histologic
feature of NPHP consists of development of renal fibrosis, which, in chronic renal failure of any origin, represents
the pathogenic event correlated most strongly to loss of renal function. Four gene loci for NPHP have been mapped
to chromosomes 2q13 (NPHP1), 9q22 (NPHP2), 3q22 (NPHP3), and 1p36 (NPHP4). At all four loci, linkage has
also been demonstrated in families with the association of NPHP and retinitis pigmentosa, known as “Senior-Løken
syndrome” (SLS). Identification of the gene for NPHP type 1 had revealed nephrocystin as a novel docking protein,
providing new insights into mechanisms of cell-cell and cell-matrix signaling. We here report identification of the
gene (NPHP4) causing NPHP type 4, by use of high-resolution haplotype analysis and by demonstration of nine
likely loss-of-function mutations in six affected families. NPHP4 encodes a novel protein, nephroretinin, that is
conserved in evolution—for example, in the nematode Caenorhabditis elegans. In addition, we demonstrate two
loss-of-function mutations of NPHP4 in patients from two families with SLS. Thus, we have identified a novel
gene with critical roles in renal tissue architecture and ophthalmic function.
Introduction
Nephronophthisis (NPHP), an autosomal recessive cystic
kidney disease, constitutes the most frequent genetic cause
of end-stage renal disease (ESRD) in children and young
adults, necessitating renal replacement therapy for sur-
vival (Smith and Graham 1945; Fanconi et al. 1951; Hil-
debrandt 1999). Three distinct gene loci for NPHP—
NPHP1 (MIM 256100), NPHP2 (MIM 602088), and
NPHP3 (MIM 604387)—have been mapped to chro-
mosomes 2q13 (Antignac et al. 1993; Hildebrandt et al.
1993), 9q22 (Haider et al. 1998), and 3q22 (Omran et
al. 2000), respectively. These disease variants share renal
histology of interstitial infiltrations, renal tubular cell at-
rophy with cyst development, and renal interstitial fibrosis
(Waldherr et al. 1982). The variants can be distinguished
clinically by age at onset of ESRD. The most prominent
histologic feature of NPHP is renal fibrosis, which, in
chronic renal failure, regardless of origin, represents the
pathogenic event that is correlated most strongly to loss
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of renal function (Zeisberg et al. 2001). Therefore, NPHP
has been considered a model disease for the development
of renal fibrosis.
We have previously identified, by positional cloning,
the gene (NPHP1) for NPHP type 1 (Hildebrandt et al.
1997). Its gene product, nephrocystin, represents a
novel docking protein that interacts with the signaling
proteins p130Cas, tensin, focal adhesion kinase 2, and
filamins A and B, which are involved in cell-cell and
cell-matrix signaling of renal epithelial cells (Donaldson
et al. 2000, 2002; Hildebrandt and Otto 2000; Benzing
et al. 2001). The association between NPHP and au-
tosomal recessive retinitis pigmentosa (RP) has been de-
scribed as the so-called “Senior-Løken syndrome” (SLS
[MIM 266900]) (Løken et al. 1961; Senior et al. 1961).
In families with SLS, linkage has been demonstrated to
the loci for NPHP1 and NPHP3 (Caridi et al. 1998;
Omran et al. 2002). Very recently, we have localized a
new gene locus (NPHP4 [MIM 606966]) for NPHP type
4 (Schuermann et al. 2002), and we have demonstrated
linkage to this locus in a large kindred with SLS.
We here identified, by positional cloning, the gene
(NPHP4) that causes NPHP type 4, through demon-
stration of nine likely loss-of-function mutations in six
affected families. In addition, we detected two loss-of-
function mutations in patients from two families with
SLS. NPHP4 is a novel gene that is unrelated to any
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Table 1
Clinical Details and Mutations Detected in Families with NPHP4
Family
Number
of Affected
Individuals
ESRD
at Agea
(years) RP Origin
Parental
Consanguinity Exon
Nucleotide
Changeb
Effect
on Coding
Sequence Segregationc
F3d 3 28, 30, 35 Yes Turkey Yes 18 C2335T Q779X Hom
F24 2 ND No Germany No 17 G2260A G754R P
17 IVS16-1 GrC Splice site M
F30d 3 18, 22, 22 No Germany Yes 23 3272delT Stop at codon L1121 Hom
F32 2 19, 20 No India Yes 11 TC1334-1335AA F445X Hom
F60 4 6, 10, 17, 22 Yes France Yes 16 C1972T R658X Hom
F444d 2 23, 33 No Finland No 15 IVS151 GrA Splice site M
24 IVS241 GrA Splice site P
F461d 3 ND No France No 16 C2044T R682X P
19 C2542T R848W M
F622 2 8, 9 No Afghanistan Yes 18 G2368T E790X Hom
a ND p no data available.
b All mutations were absent from 92–96 unaffected control individuals.
c M p maternal; P p paternal; Hom p homozygous mutation inherited from both parents.
d In these four families, linkage to NPHP4 has been published elsewhere (Schuermann et al. 2002).
known gene families. It encodes a novel protein, nephro-
retinin. NPHP4, like NPHP1, is unique to the human
genome, is conserved in Caenorhabditis elegans, and
exhibits a broad expression pattern. It is therefore likely
that both gene products, nephroretinin and nephrocys-
tin, interact within a novel shared pathogenic pathway.
Thus, we have identified a novel gene with critical roles
in renal tissue architecture and ophthalmic function.
Subjects and Methods
Pedigree and Diagnosis
We obtained blood samples and pedigrees after re-
ceiving informed consent from patients with NPHP and
their parents. Diagnostic criteria were (1) development
of ESRD in addition to a history of polyuria, polydip-
sia, and anemia; and (2) renal ultrasound compatible
with NPHP. In all families except F461, the diagnosis
of NPHP was confirmed by renal biopsy. ESRD de-
veloped within a range of 6–35 years of age with a
median age of 22 years (table 1). In SLS, the renal
symptoms are associated with RP. Clinical data for
family F3 (with SLS) have been published elsewhere
(Polak et al. 1983; Schuermann et al. 2002). All three
affected siblings had RP suggestive of Leber amaurosis
congenita. Ophthalmologic data for family F60 have
been published elsewhere (Fillastre et al. 1976) and
comprise the following observations: In one individual
(Fillastre et al. 1976), there was amblyopia and rotary
nystagmus with grossly impaired vision starting at age
8 mo, and, on fundoscopy, there was retinochoroidal
atrophy surrounded by pigment. In two individuals,
there were abnormal ERG findings with diminished
amplitude (Fillastre et al. 1976).
Haplotype and Mutational Analysis
The “screening markers” used for haplotype analysis
consisted of microsatellites markers D1S2845, D1S2660,
D1S2795, D1S2870, D1S2642, D1S214, D1S2663, and
D1S1612 (in pterrcen orientation) (Dib et al. 1996).
Novel microsatellite markers were generated by searching
for di-, tri-, and tetranucleotide repeats, using the BLAST
program on human genomic sequence in the interval be-
tween flanking markers D1S2660 and D1S2642. Prepa-
ration of genomic DNA and haplotype analysis were per-
formed as described elsewhere (Schuermann et al. 2002).
Mutational analysis was performed using exon-flanking
primers, as described elsewhere (Hildebrandt et al. 1997).
Primer sequences can be obtained from the authors.
Northern Blot Analysis
A multiple-tissue northern blot with human adult
poly(A) RNA (MTN7760-1; Clontech) was hybridized
with an NPHP4 DNA probe of 584 bp, derived from
exon 30 (nucleotides 4141–4724; see fig. A [online
only]) and generated by PCR amplification of human
genomic DNA. The probe was labeled with [32P]dCTP
by using Random Primers DNA Labeling System (In-
vitrogen). Hybridization was performed at 68C by us-
ing ExpressHyb solution (Clontech). The final washing
condition was 0.1 # saline sodium citrate, 0.1% SDS,
at 55C for 40 min.
Results
We have previously mapped, by total-genome search
for linkage, a gene locus (NPHP4) for NPHP type 4
within a 2.1-Mb interval delimited by flanking mark-
ers D1S2660 and D1S2642 (Schuermann et al. 2002).
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Figure 1 Haplotype results on chromosome 1p36 performed for
refinement of the NPHP4 locus in affected offspring from three con-
sanguineous families with NPHP. Family, generation, and individual
numbers are indicated above haplotypes. Paternal haplotypes are
shown on blue background, and maternal haplotypes are shown on
yellow background. A recombination in the maternal haplotype, which
was directly observed in parent-to-child transmission in this pedigree,
is shown on orange background. At left, 8 published microsatellites
are given in italic, and 38 newly generated microsatellites are given in
roman. Flanking markers to the published 2.1-Mb critical NPHP4
interval are depicted in red. Informative alleles are underlined. Hap-
lotypes homozygous in continuity are encased in boxes. Homozygosity
mapping revealed a p-terminal recombinant for marker D1E23 (as-
terisks) on the basis of heterozygosity in individuals F30 II-2 and F30
II-3 and an observed recombinant for marker SNP-KIAA0720-Ex19
(asterisks) in individual F30 II-3, thus refining the critical genetic region
to a secure interval !1.2 Mb. On the basis of a significant LOD score
yielded for F30 alone (Schuermann et al. 2002), this refinement yields
secure borders. Further refinement was achieved through heterozy-
gosity for markers D1E19 and D1S2870 (double asterisks) in individ-
uals F32 II-1 and F60 II-1, respectively. This refines the critical genetic
region to a suggestive interval !700 kb. Because of the presence of
only two affected individuals in each family, this refinement is only
suggestive. p-ter p Telomeric; cen p centromeric; nd p not done.
To establish compatibility with linkage to NPHP4 in
further kindreds, we selected 20 families with multiple
affected children or parental consanguinity, in whom
no mutation was present in the NPHP1 gene. In 12
families, there was NPHP only, and, in 8 families,
there was an association between NPHP and RP. Hap-
lotype analysis using eight microsatellite markers cov-
ering the critical NPHP4 region (Schuermann et al.
2002) was compatible with linkage to NPHP4 in nine
families. To further refine the critical genetic interval
of 2.1 Mb, we performed high-resolution haplotype
analysis in these nine families and in the seven families
with linkage to NPHP4 published elsewhere (Schuer-
mann et al. 2002). In a total of three families, NPHP
was associated with RP. These were two families (F18
and F60) from the new set of nine linked families and
one family (F3) that has been described elsewhere
(Schuermann et al. 2002). Eight published (Dib et al.
1996) and 38 newly generated microsatellite markers
(table A [online only]) were used at an average marker
density of one marker per 45 kb within the interval
of flanking markers D1S2660 and D1S2642 (fig. 1).
Haplotype analysis, by the criterion of minimization
of recombinants, clearly revealed erroneous inversion
of sequence between markers D1S2795 and D1S244
in human genomic sequence databases (see the En-
sembl Genome Browser Web site) (data available from
the authors); this inversion was not described in the
recent high-resolution genetic map of the human ge-
nome (Kong et al. 2002). Using high-resolution hap-
lotype data, we established the correct marker order
at the NPHP4 locus as pter-D1S2660-D1S2795-
D1S2633-D1S2870-D1S253-D1S2642-D1S214-
D1S1612-D1S2663-D1S244-cen (flanking markers to
NPHP4 are underlined) (Schuermann et al. 2002). A
22-kb sequence gap remaining in the interval
D1S2660-D1S2795 was filled by use of Celera human
genomic sequence. In haplotype analysis, three con-
sanguineous kindreds yielded new key recombinants
by the criterion of homozygosity by descent (Lander
and Botstein 1987) (fig. 1). We thus refined the
NPHP4 critical genetic interval to !1.2 Mb within
secure borders that were based on a large kindred,
and, in addition, to !700 kb within suggestive borders
that were based on two small families (figs. 1, 2A,
and 2B).
Within the 700-kb critical interval for NPHP4, there
mapped three known genes (KCNAB2, RPL22, and
ICMT) and three unknown genes (Q9UFQ2,Q9UFR9,
and Q96MP2) (fig. 2B). In addition, in the interval be-
tween Q9UFQ2 and flanking marker D1E19 (fig. 2B),
the program GENESCAN predicted ∼40 nonannotated
exons (see the Ensembl Genome Browser Web site) (data
not shown). We performed mutational analysis in af-
fected individuals from the 16 families compatible with
linkage to NPHP4, examining all 79 exons of the three
known and three unknown genes by direct sequencing
of the forward strands of exon-PCR products. Although
no mutations were detected in five of these genes, in
Q9UFQ2, we detected 11 distinct mutations in 8 of the
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Figure 2 Positional cloning strategy for the NPHP4 gene, on human chromosome 1p36. A, Genetic map position for microsatellites used
in linkage mapping of NPHP4 (see fig. 1). Sex-averaged genetic distance (in cM) from the Marshfield map was used. Published flanking markers
are underlined (Schuermann et al. 2002). p-ter p Telomeric; cen p centromeric. B, Physical map distances of critical microsatellites relative
to D1S2660. The secure 1.2-Mb critical interval (solid bar) and the 700-kb suggestive critical interval (stippled bar) are delimited by the newly
identified secure flanking markers (asterisks) and suggestive flanking markers (double asterisks) defined by haplotype analysis (see fig. 1). Below
the axis, known genes (green), predicted unknown genes (blue), and the NPHP4 gene (also known as “Q9UFQ2”) are represented as arrows
in the direction of transcription. C, Genomic organization of NPHP4, with exons indicated by vertical hatches and numbered. D, Exon structure
of NPHP4 cDNA. Blackened and unblackened boxes represent the 30 exons encoding nephroretinin. The number of the first codon of each
exon is indicated; exons beginning with the second or third base of a codon are indicated by “b” or “c,” respectively. At bottom, locations of
the 11 different mutations identified in eight kindreds with NPHP4 mutations are shown. fs p Frameshift. E, NPHP4 mutations occurring
homozygously in affected individuals from five consanguineous families (underlined). Compound heterozygous mutations are not shown. Mutated
nucleotides and altered amino acids are depicted on gray background.
16 families with NPHP (table 1). In families F3 and F60,
NPHP is associated with RP. In the affected individuals
from all eight families, mutations were shown to segre-
gate from both parents (table 1). All of these mutations
were absent from 92–96 unaffected control individuals
from a similar ethnic background. Of the 11 mutations
detected, 9 represent very likely loss-of-function muta-
tions: 5 were stop-codon mutations, 1 was a frameshift
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Figure 3 Northern blot analysis of the NPHP4 expression pat-
tern. A multiple-tissue northern blot with human adult poly(A) RNA
was hybridized with a 584-bp NPHP4 human DNA probe. Expression
of a 5.0-kb transcript (arrowhead) is apparent in all tissues studied,
with highest expression being in skeletal muscle.
mutation, and 3 were obligatory splice-consensus mu-
tations (table 1 and fig. 2D). We thus identifiedQ9UFQ2
as the gene that causes NPHP type 4. The gene was
termed “NPHP4,” and the respective gene product was
called “nephroretinin” for its role in NPHP and RP. In
the five consanguineous families—F3, F30, F32, F60, and
F622—all mutations occurred in the homozygous state
and represented stop-codon mutations and one frame-
shift mutation, truncating the protein in exons 18, 23,
11, 16, and 18, respectively (table 1 and figs. 2D and
2E). In the three nonconsanguineous families, we found
six distinct compound heterozygous mutations. Four rep-
resented stop-codon or obligatory splice-consensus mu-
tations, truncating the gene product in exons 15, 16, 17,
and 24. The missense mutations R848W and G754R
affect amino acid residues conserved in mouse and cow.
No mutations were detected in eight families.
NPHP4 expression studies by northern blot analysis
revealed a 5.0-kb transcript expressed strongly in human
skeletal muscle, weakly in kidney, and in six additional
tissues studied (fig. 3). Northern dot blot analysis (data
not shown) confirmed a widespread expression pattern
in human adult and fetal tissues, including testis. This
broad expression pattern, with strong expression in skel-
etal muscle and testis, corresponds well with the expres-
sion pattern described for the NPHP1 gene (Otto et al.
2000).
Human genomic sequence of NPHP4 was assembled
using the Homo sapiens chromosome 1 working draft
sequence segment NT_028054, which predicted 25 ex-
ons. Five additional 5′ exons were identified using ad-
ditional working draft sequence—in particular, the
mRNA KIAA0673 and 57 human ESTs from UniGene
cluster Hs.106487. The genomic structure shown in
figures 2C, 2D, and A was confirmed by human/mouse
total-genomic-sequence comparison. The NPHP4 gene
contains 30 exons encoding 1,426 amino acids and
extends over 130 kb, with splice sites that confirm to
the canonical consensus gt-ag. An exception was found
in intron 24, with gc-ag splicing, which occurs in 0.5%
of mammalian splice sites (Burset et al. 2001). A poly-
morphism is known to be present at the intron 20
splice acceptor (tg for ag). The presence of exon 20 is
supported by three human EST clones. Ten different
splice variants have been suggested for KIAA0673 (see
the AceView Web site).
TheNPHP4 cDNA (fig. A) and deduced nephroretinin
protein sequences were found to be novel, without any
sequence similarity to known human cDNA or protein
sequences. Therefore, NPHP4 encodes a hitherto un-
known protein. As shown for the NPHP1 gene product
nephrocystin (Hildebrandt et al. 1997; Otto et al. 2000),
there was, however, strong sequence conservation for
nephroretinin in evolution, with 23% amino acid identity
in a protein ofC. elegans (fig. B [online only]). Translated
ESTs also demonstrated evolutionary conservation in
mouse, cow, pig, zebrafish,Xenopus laevis, Ascaris suum,
and Halocynthia roretzi. Sequence identity of the murine
ortholog was 78% (fig. B). Analysis of nephroretinin
amino acid sequence (see the ExPASy Molecular Biology
Server Web site) provided no signal sequence, conserved
domains, or predicted transmembrane regions. Instead,
in the N-terminal half, there was a putative nuclear lo-
calization signal, a glutamate-rich domain, and a proline-
rich domain. The latter two domains have also been
found in nephrocystin (Otto et al. 2000). No sequence
similarity to nephrocystin was present. In addition, two
serine-rich sequences and a C-terminal endoplasmic re-
ticulum membrane domain, were found in human and
murine nephroretinin sequences. Encoded by exons 15
and 16, there was, in nephroretinin, a domain of un-
known function (DUF339) with evolutionary conserva-
tion dating back to prokaryotes and a 63-amino-acid
stretch with 30% sequence identity to a gas-vesicle pro-
tein of Halobacterium salinarium (fig. B).
Discussion
Our conclusion that we have identified the gene causing
NPHP type 4 is based on the identification, in eight
families with NPHP, of nine distinct truncating muta-
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tions and two missense mutations, none of which oc-
curred in 192 unaffected control individuals. The ab-
sence of mutations in eight additional families with
NPHP is not surprising, since linkage in kindreds with
only two affected individuals can be fortuitous and since
NPHP in these families may be caused by mutations in
the NPHP3 gene, which has not yet been identified (Om-
ran et al. 2000). This finding may also indicate further
genetic locus heterogeneity for NPHP. Here we also dem-
onstrate the presence of two homozygous truncating mu-
tations in two families with SLS (F3 and F60). Interest-
ingly, a small percentage of patients also exhibit SLS in
families with NPHP1 mutations (Caridi et al. 1998) and
in families with linkage to NPHP3 (Omran et al. 2002).
For all three genes, no distinction can be made on the
basis of allelic differences between the NPHP phenotypes
with and without RP. Therefore, it seems likely that mod-
ifier genes may be responsible for the occurrence of RP
in NPHP types 1, 3, and 4. NPHP4, like NPHP1, is
unique to the human genome, is conserved in C. elegans,
and exhibits a broad expression pattern. It is possible that
their gene products, nephroretinin and nephrocystin, re-
spectively, interact within a novel shared pathogenic path-
way. Since identification of theNPHP1 gene (Hildebrandt
et al. 1997) had revealed nephrocystin as a novel docking
protein that interacts with p130Cas (Donaldson et al.
2000; Hildebrandt and Otto 2000), tensin, focal adhesion
kinase 2 (Benzing et al. 2001), and filamins A and B
(Donaldson et al. 2002), which are involved in cell-cell
and cell-matrix signaling, further studies will have to de-
termine the functional role that nephroretinin plays within
those interactions. Studies into the function of nephroreti-
nin will provide new insights into disease mechanisms of
renal fibrosis, cyst development, and visual function.
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